DPH to Distribute Overdose Reversing Medication Naloxone March 2, 2019 at Attack Addiction 5K
نویسندگان
چکیده
منابع مشابه
Take-home naloxone kits preventing overdose deaths.
injected naloxone into a fellow drug user to save his life, she was crouched in a tent in the mountains outside Nelson, British Columbia. Friends in a nearby tent had awoken her with news that one of their companions had overdosed on methadone. Grabbing her flashlight, a bottle of naloxone and a clean syringe, Shaver raced to help. The man had been smoking cocaine and drinking alcohol and metha...
متن کاملFailure of naloxone to reverse the cardiotoxocity of Distalgesic overdose.
An 18-year-old youth presented half an hour after taking approximately 50 of his mother's Distalgesic tablets (containing dextropropoxyphene 32-5 mg and paracetamol 325 mg per tablet) following a moderate amount of beer. He was noted to have brief fits in the ambulance and on arrival in hospital was having intermittent tonic spasms lasting about 30 seconds. Between these his respiration was nor...
متن کاملPrescription naloxone: a novel approach to heroin overdose prevention.
The mortality and morbidity from heroin overdose have increased in the United States and internationally in the last decade. The lipid solubility allows the rapid deposition of heroin and its metabolites into the central nervous system and accounts for the "rush" experienced by users and for the toxicity. Risk factors for fatal and nonfatal heroin overdoses such as recent abstinence, decreased ...
متن کاملIntranasal naloxone is a viable alternative to intravenous naloxone for prehospital narcotic overdose.
OBJECTIVE To compare the prehospital time intervals from patient contact and medication administration to clinical response for intranasal (IN) versus intravenous (IV) naloxone in patients with suspected narcotic overdose. METHODS This was a retrospective review of emergency medical services (EMS) and hospital records, before and after implementation of a protocol for administration of intran...
متن کاملFDA confronts opioid addiction and overdose deaths.
“We're going to fundamentally re-examine the risk-benefit paradigm for opioids and ensure that we consider their wider public health effects”, said Robert Califf (FDA, Silver Spring, MD, USA) at a press conference on February 4. The agency's plan includes improved transparency in the drug approval process for opioids, convening of expert panels, commissioning of clinical and observational studi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Delaware Journal of Public Health
سال: 2019
ISSN: 2639-6378
DOI: 10.32481/djph.2019.02.008